Pimobendan prah je akind of drug created express for use in Veterinary Medicine. Congestive heart failure (CHF) and dilated Cardiomiopati are two heart diseases that are Tipično Treated With Pimobendan, A Positive Inotropic Drug And Vazodilator. It aids in enhancing srčani kontraktilnost i eases blood vessel tension, which leads to improved pumping effectiveness and lessened heart soj. Psi s srce uvjeti takvi prošireni kardiomiopatija or mitral ventil disfunkcija često take veterinarski pimobendan. It is given animals under a veterinar's supervision to treat srčani problems and improve their their general cardiovascular health.
Što Type Of Medication Is Pimobendan
Veterinary pimobendan is a drug that has been especial proizveden and designed for use in animals. It is mostly used to treat a lot of srčan bolesti. It is a member of the therapeutic class of vazodilatator i pozitivni inotropni lijekovi, oboje of which are frequently employed in veterinary cardiology.
As a positive inotropic agent, veterinary pimobendan works by enhancing the contractilty of the heart muscle. It senzibilizes the srčan miociti to kalcij, leading to increased force of kontrakcija and poboljšan srčan izlaz. Ova mehanizam je uslužno to poboljšati e učinkovitost srce funkcija in životinje sa kompromitiranim kardiovaskularnim sustavima.
Dodatno, fosfodiesteraza III (PDE III) is inhibiran by veterinarsko pimobendan. Ciklički adenozin monofosfat (cAMP), a tvar uključeno in intracelularno signaliz putovi, is čuvano od being broken down by blocking PDE III. Increased calcium levels in the srčan cells as a result of cAMP buildup improve contractility even further.
Veterinarski pimobendan opušta the the glatka mišići lining the the blood arteries as part of its vazodilatory actions. Vasodilation, which expands the blood arteries and lowers periferal resistance, is the effect of this. As a result of the dew resistance, the cardiovascular system's blood flow and pressure can be enhanced, reducing stress on the heart.
Veterinarski pimobendan is most obično korišten in psi, posebno oni dijagnosticirani sa srcem bolesti takv kao prošireno kardiomiopatija (DCM) or mitral ventil bolest (MVD). It can enhance overall srčana funkcija in ove životinje i help manage the symptoms of kongestivno srce neuspjeh (CHF).
Što Je Pimobendan Rabljeno Za In Životinje
Dogs in particular are treated with pimobendan for a variety of heart problems. In dogs with specific srčane bolesti, it is frequently given by veterinari to control kongestivno srce neuspjeh (CHF) i enhance kardiovaskularna funkcija.
Liječenje proširena kardiomiopatija (DCM) is one of the main uses of pimobendan in animals. In DCM, the heart muscle enlarges and bes weaker, resulting in a reduction in in in heart in in heart in symptoms. It reduces symptoms and improves of life in dogs with DCM by helping the heart's ability to contract more effectively.
The treatment of mitral valve disease (MVD), a prevalent heart problem in older dogs, with pimobendan is also common. The mitral valve worses with MVD, enabling blood to flow back into the left atrium. Volume overload and eventualn srčani failure may result from this. Pimobendan can help help compensate for the malfunctioning valve and enhance srčani function in dogs with MVD by improving the heart's muskular kontraktilnost.
Pimobendan may also be used to prevent heart disease in breeds that are predisponiran to it, such as some small and toy pasmine. The development or emergence of heart problems may be slowed down, allowing dogs to live healthier, longer lives.
It's crucial to remember that pimobendan should only be administriran with a veterinar's advice and prescription. The animal's condition, weight, and general health will be taken into consideration while determining the the dosage and administration schedule. The success the the treatment must be evaluated frequently, the the dosage must be changed as needed.
Is Pimobendan A Kalcij Kanal Blokator
No, pimobendan is not a a calcium channel blocker. It belongs to a different class of medications known as positive inotropic agents or phosphodiesterase III (PDE III) inhibitori. While it may have similar effects on the heart as calcium channel blockers, its mechanism of action and therapeutic benefits are distinct.
Kalcij kanal blokatori (CCB) rad by blokiranje the ulaz od kalcij ioni u srčani i glatko mišićne stanice. By inhibicija kalcij priljev, CCBs dereduce the contractilty of the heart muscle and relax the the glatke mišiće lining krv žile. Ovo vodi to vazodilatacija, reducirano periferno otpor, i smanjeno krv tlak.
Umjesto toga than izravno preventing the the entry of calcium ions, pimobendan works by making the heart muscle more kontraktil. It makes the myocytes more calcium-sensitive, which improves calcium binding in the muscle cells. As a result, the force of srčani kontrakcije increases, inass the heart's ability to pump blood more effectively.
Pimobendan also funkcije as a PDE III inhibitor. Ciklički adenozin monofosfat (cAMP), a tvar implicated in intracellular signaling pathways, is kept from dezintegracija by inhibicija PDE III. The myocardial cells' increased cAMP levels result in a number of downstream processes that further improve contractilty.
The distinctive inotropic effect of pimobendan is a result of the interaction between enhanced calcium sensitivity and PDE III inhibicija. This drug dilates blood arteries, lowers periferno otpor, and lessens the stress on the heart while increasing the strength and efficiency of srčano kontrakcije.
If you want to know more about this product, feel free to contact Xi'an Sonwu.
E-pošta: sales@sonwu.com